Home Newsfeeds Northcoast Research Downgrades Wendy’s to Neutral

Northcoast Research Downgrades Wendy’s to Neutral

Northcoast Research analyst Jim Sanderson downgrades Wendy's (NASDAQ:WEN) from Buy to Neutral.

byBenzinga Newsdesk

March 6, 2023

1 minute read

Northcoast Research analyst Jim Sanderson downgrades Wendy’s (NASDAQ:WEN) from Buy to Neutral.

Analyst Ratings

Analyst Ratings for 4D Molecular Therapeutics

By Benzinga Insights

June 8, 4:00 PM

Within the last quarter, 4D Molecular Therapeutics (NASDAQ:FDMT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

FDMT

‘Black Swan’ Author Says Crypto Is A ‘Tumor,’ Bitcoin Is Fated To Either Kill The Host Or Self-Destroy

By Adam Eckert

June 22, 11:28 AM

"Black Swan" author Nassim Nicholas Taleb says the cryptocurrency market is a tumor and the price of Bitcoin (CRYPTO: BTC) is being propped up by a cult.

BTC

‘Right Now I Don’t Want To Back Away From It,’ Jim Cramer Says About This Stock Down Only 8% This Year

By Lisa Levin

October 24, 7:58 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he doesn’t want to back away from Iron Mountain Incorporated (NYSE: IRM) right now. "We may have to do new work on Iron Mountain to see if it’s as safe as we think it is," he added.

Why Nutex Health (NUTX) Shares Are Trading Higher

By Henry Khederian

April 12, 8:37 AM

Nutex Health Inc (NASDAQ: NUTX) shares are trading higher by 15.04% to $1.10 Wednesday morning after the company announced it entered into a $100 million pre-paid advance agreement with Yorkville Advisors Global.

NUTX

Northcoast Research Downgrades Wendy’s to Neutral

Related Posts

Analyst Ratings for 4D Molecular Therapeutics

‘Black Swan’ Author Says Crypto Is A ‘Tumor,’ Bitcoin Is Fated To Either Kill The Host Or Self-Destroy

‘Right Now I Don’t Want To Back Away From It,’ Jim Cramer Says About This Stock Down Only 8% This Year

Why Nutex Health (NUTX) Shares Are Trading Higher